EMMAC Life Sciences

EMMAC Life Sciences

European Medical Cannabis Company.

HQ location
London, United Kingdom
Website
emmac.com
Launch date
Employees
51-200 people
Enterprise value
$286m
Company register number
11253633
Recent deals
https://twitter.com/emmaclsghttps://www.linkedin.com/company/curaleafint/
    • Edit
loading funding rounds…
Altitude Investment Management
Altitude Investment Management(exited)
Curaleaf
Curaleaf
Material V
Material V(exited)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
GBP20182019202020212022
Revenues00000000000000000000
% growth--140 %36 %40 %
EBITDA00000000000000000000
% EBITDA margin-(187 %)(62 %)(155 %)(70 %)
Profit00000000000000000000
% profit margin-(201 %)(74 %)(242 %)(127 %)
EV00000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x
R&D budget00000000000000000000

Source: Company filings or news article

Related Content

More about EMMAC Life Sciences
Edit

Curaleaf Medical is the scientific arm of Curaleaf International. Our team focuses on advancing our understanding of the potential therapeutic value of cannabis used for medicinal purposes (also known as medical marajuana) and how we can develop products that meet the needs of people all across Europe.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Investments by EMMAC Life Sciences

Edit
Blossomswiss
Blossomswiss
ACQUISITION by EMMAC Life Sciences Jan 2019